Decreased serum BDNF levels in patients with epileptic and psychogenic nonepileptic seizures

Neurology

Volumn 75, Issue 14, 2010, Pages 1285-1291

  Lafrance Jr , W C ^a,b   Leaver, K ^d   Stopa, E G ^a,b   Papandonatos, G D ^c   Blum, A S ^a,b  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

^c Community Health Biostatistics ^*  (United States)

^d BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSYCHOGENIC NONEPILEPTIC SEIZURE; SEIZURE; AGED; ANALYSIS OF VARIANCE; BLOOD; ELECTROENCEPHALOGRAPHY; EPILEPSY; GENETICS; METHODOLOGY; MIDDLE AGED; PSYCHOLOGICAL ASPECT; PSYCHOSOMATIC DISORDER;

ADULT; AGED; ANALYSIS OF VARIANCE; BRAIN-DERIVED NEUROTROPHIC FACTOR; ELECTROENCEPHALOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHOPHYSIOLOGIC DISORDERS; SEIZURES; YOUNG ADULT;

EID: 77958176810     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181f612bb     Document Type: Article

References (37)

1. Chen DK, So YT, Fisher RS. Use of serum prolactin in diagnosing epileptic seizures: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2005;65:668-675.
2. Connolly AM, Chez M, Streif EM, et al. Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy. Biol Psychiatry 2006;59:354-363.
3. Deveci A, Aydemir O, Taskin O, Taneli F, Esen-Danaci A. Serum brain-derived neurotrophic factor levels in conversion disorder: comparative study with depression. Psychiatry Clin Neurosci 2007;61:571-573. (Pubitemid 47414862)
4. Trajkovska V, Marcussen AB, Vinberg M, Hartvig P, Aznar S, Knudsen GM. Measurements of brain-derived neurotro-phic factor: methodological aspects and demographical data. Brain Res Bull 2007;73:143-149.
5. Monteleone P, Tortorella A, Martiadis V, Serritella C, Fuschino A, Maj M. Opposite changes in the serum brain-derived neurotrophic factor in anorexia nervosa and obesity. Psychosom Med 2004;66:744-748.
6. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 2002;109:143-148.
7. Vuilleumier P. Hysterical conversion and brain function. Prog Brain Res 2005;150:309-329.
8. Voon V, Brezing C, Gallea C, et al. Emotional stimuli and motor conversion disorder. Brain 2010;133:1526-1536.
9. LaFrance WC Jr, Barry JJ. Update on treatments of psychological nonepileptic seizures. Epilepsy Behav 2005;7: 364-374.
10. Shimizu E, Hashimoto K, Okamura N, et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 2003;54:70-75. (Pubitemid 36776725)
11. Cunha AB, Frey BN, Andreazza AC, et al. Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neurosci Lett 2006; 398:215-219.
12. Ciammola A, Sassone J, Cannella M, et al. Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients. Am J Med Genet B Neuro-psychiatr Genet 2007;144B:574-577.
13. Laske C, Stransky E, Leyhe T, et al. Stage-dependent BDNF serum concentrations in Alzheimer's disease. J Neural Transm 2006;113:1217-1224.
14. Hashimoto K, Iwata Y, Nakamura K, et al. Reduced serum levels of brain-derived neurotrophic factor in adult male patients with autism. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:1529-1531.
15. Azoulay D, Vachapova V, Shihman B, Miler A, Karni A. Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: reversal by glatiramer acetate. J Neuroimmunol 2005;167:215-218.
16. Reis HJ, Nicolato R, Barbosa IG, Teixeira do Prado PH, Romano-Silva MA, Teixeira AL. Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia. Neurosci Lett 2008;439: 157-159.
17. Laske C, Stransky E, Eschweiler GW, et al. Increased BDNF serum concentration in fibromyalgia with or without depression or antidepressants. J Psychiatr Res 2007;41: 600-605.
18. Nelson KB, Grether JK, Croen LA, et al. Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann Neurol 2001;49:597-606.
19. Gotz R, Koster R, Winkler C, et al. Neurotrophin-6 is a new member of the nerve growth factor family. Nature 1994;372:266-269.
20. Schlessinger J, Ullrich A. Growth factor signaling by receptor tyrosine kinases. Neuron 1992;9:383-391.
21. Strohmaier C, Carter BD, Urfer R, Barde YA, Dechant G. A splice variant of the neurotrophin receptor trkB with increased specificity for brain-derived neurotrophic factor. Embo J 1996;15:3332-3337.
22. Dechant G. Molecular interactions between neurotrophin receptors. Cell Tissue Res 2001;305:229-238.
23. Bengzon J, Kokaia Z, Ernfors P, et al. Regulation of neuro-trophin and trkA, trkB and trkC tyrosine kinase receptor messenger RNA expression in kindling. Neuroscience 1993;53:433-446.
24. Balkowiec A, Katz DM. Activity-dependent release of endogenous brain-derived neurotrophic factor from primary sensory neurons detected by ELISA in situ. J Neurosci 2000;20:7417-7423.
25. Poduslo JF, Curran GL. Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF. Brain Res Mol Brain Res 1996;36:280-286.
26. Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 1998;37:1553-1561.
27. Karege F, Schwald M, Cisse M. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett 2002;328:261-264.
28. Ernfors P, Bengzon J, Kokaia Z, Persson H, Lindvall O. Increased levels of messenger RNAs for neurotrophic factors in the brain during kindling epileptogenesis. Neuron 1991;7:165-176.
29. Shetty AK, Zaman V, Shetty GA. Hippocampal neurotro-phin levels in a kainate model of temporal lobe epilepsy: a lack of correlation between brain-derived neurotrophic factor content and progression of aberrant dentate mossy fiber sprouting. J Neurochem 2003;87:147-159.
30. Murray KD, Isackson PJ, Eskin TA, et al. Altered mRNA expression for brain-derived neurotrophic factor and type II calcium/calmodulin-dependent protein kinase in the hippocampus of patients with intractable temporal lobe epilepsy. J Comp Neurol 2000;418:411-422.
31. Takahashi M, Hayashi S, Kakita A, et al. Patients with temporal lobe epilepsy show an increase in brain-derived neurotrophic factor protein and its correlation with neu-ropeptide Y. Brain Res 1999;818:579-582.
32. Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006;59: 1116-1127.
33. Aid T, Kazantseva A, Piirsoo M, Palm K, Timmusk T. Mouse and rat BDNF gene structure and expression revisited. J Neurosci Res 2007;85:525-535.
34. Ma DK, Jang MH, Guo JU, et al. Neuronal activity-induced Gadd45b promotes epigenetic DNA demethylation and adult neurogenesis. Science 2009;323:1074-1077.
35. Nibuya M, Morinobu S, Duman RS. Regulation of BDNF and trkB mRNA in rat brain by chronic electro-convulsive seizure and antidepressant drug treatments. J Neurosci 1995;15:7539-7547.
36. Beck KD, Lamballe F, Klein R, et al. Induction of non-catalytic TrkB neurotrophin receptors during axonal sprouting in the adult hippocampus. J Neurosci 1993;13: 4001-4014.
37. Bittigau P, Sifringer M, Genz K, et al. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci USA 2002;99:15089-15094. (Pubitemid 35334614)